Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 14 of 25
Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke
NCT02703532
The Effect of Dopamine on Diabetic Retinopathy
NCT02706977
Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
NCT02614508
Tapering Off Antidepressants
NCT02661828
Vitamin D and Microbiota in Cystic Fibrosis
NCT02589444
Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients
NCT02544503
Targeted Fusion Biopsy of the Prostate
NCT02744534
Anterior Cruciate Ligament Pain Study
NCT02604550
Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
NCT02513485
Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
NCT02408120
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
NCT02572648
Direct Instruction Language for Learning in Autism Spectrum Disorder
NCT02483910
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
NCT02455076
Bela 8 Week Dosing
NCT02560558
Mental Stress Ischemia: Biofeedback Study
NCT02657382
Metformin and Congenital Nephrogenic Diabetes Insipidus
NCT02460354
Field Implementation of iDETECT
NCT02529618
The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project
NCT02562092
Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth
NCT02461212
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
NCT02506023
MyHeartBaby: An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program
NCT02895334
Hamstring Tightness
NCT02516137
Understanding Substance Use and Incident HIV/STI Among Young Black MSM
NCT02503618
Intervention and Outcomes in Duarte Galactosemia
NCT02519504
Use of On-Q Pump for Pain Post C-Section
NCT02579629
Heart Rate Variability in Depression
NCT02525978
Comparison of Double Lumen Tube Placement Techniques
NCT02495259
Early FMT for C.Difficile
NCT02465463
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
NCT02620514
High-Shear Microfluidic Thrombosis Assay
NCT02422810
Inflammation-Induced CNS Glutamate During Breast Cancer Treatment
NCT02421978
A Comparison of Stryker Hybrid Arch Bars
NCT02283528
Testing of Four Home Phenylalanine Monitoring Prototype Devices
NCT02445521
BraveMind: Advancing the Virtual Iraq/Afghanistan PTSD Exposure Therapy
NCT02246972
Study of Kids Itch Severity (SKIS)
NCT02672579
Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke
NCT02465034
Health Evaluation in African Americans Using RAS Therapy
NCT02471833
Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool
NCT02171312
Improving Survey Procedures for Young Men Who Have Sex With Men in Web-based HIV Prevention: Retention Study
NCT02424643
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
NCT02154061
Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT
NCT02575079
Freezing of Gait: Clinical, Cognitive, and Imaging Features
NCT02387281
PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
NCT02401230
An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
NCT02383758
A Study of the Elopement Prevention and Safety Training Program
NCT02383732
Cryoablation for Phantom Limb Pain
NCT02366832
Diabetic Ketoacidosis: Brain Morphology and Cognition
NCT02443415
Minocycline Augmentation to Clozapine
NCT02124811
Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)
NCT02043015
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
NCT02390843
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.